| Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes JC Barrett, DG Clayton, P Concannon, B Akolkar, JD Cooper, HA Erlich, ... Nature genetics 41 (6), 703-707, 2009 | 2146 | 2009 |
| Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers S Onengut-Gumuscu, WM Chen, O Burren, NJ Cooper, AR Quinlan, ... Nature genetics 47 (4), 381-386, 2015 | 681 | 2015 |
| Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation AI Petra, S Panagiotidou, E Hatziagelaki, JM Stewart, P Conti, ... Clinical therapeutics 37 (5), 984-995, 2015 | 657 | 2015 |
| Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families P Concannon, HA Erlich, C Julier, G Morahan, J Nerup, F Pociot, JA Todd, ... Diabetes 54 (10), 2995-3001, 2005 | 320 | 2005 |
| Comparative analysis of organ-specific autoantibodies and celiac disease—associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control … C Jaeger, E Hatziagelaki, R Petzoldt, RG Bretzel Diabetes care 24 (1), 27-32, 2001 | 193 | 2001 |
| Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin TC Theoharides, JM Stewart, E Hatziagelaki, G Kolaitis Frontiers in neuroscience 9, 225, 2015 | 177 | 2015 |
| IL6 Gene Promoter Polymorphisms and Type 2 Diabetes: Joint Analysis of Individual Participants’ Data From 21 Studies C Huth, IM Heid, C Vollmert, C Gieger, H Grallert, JK Wolford, B Langer, ... Diabetes 55 (10), 2915-2921, 2006 | 149 | 2006 |
| Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study PP Sfikakis, V Grigoropoulos, I Emfietzoglou, G Theodossiadis, ... Diabetes care 33 (7), 1523-1528, 2010 | 122 | 2010 |
| TNF-α, TGF-β1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus A Tsiavou, E Hatziagelaki, A Chaidaroglou, A Manginas, K Koniavitou, ... Journal of clinical immunology 24, 591-599, 2004 | 85 | 2004 |
| Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome D Farmakis, P Simitsis, V Bistola, F Triposkiadis, I Ikonomidis, S Katsanos, ... Clinical Research in Cardiology 106, 359-368, 2017 | 82 | 2017 |
| Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease V Lambadiari, NPE Kadoglou, V Stasinos, E Maratou, A Antoniadis, ... Cardiovascular diabetology 13, 1-8, 2014 | 79 | 2014 |
| Do mast cells link obesity and asthma? N Sismanopoulos, DA Delivanis, D Mavrommati, E Hatziagelaki, P Conti, ... Allergy 68 (1), 8-15, 2013 | 73 | 2013 |
| Correlation between intracellular interferon-γ (IFN-γ) production by CD4+ and CD8+ lymphocytes and IFN-γ gene polymorphism in patients with type 2 diabetes mellitus and latent … A Tsiavou, E Hatziagelaki, A Chaidaroglou, K Koniavitou, D Degiannis, ... Cytokine 31 (2), 135-141, 2005 | 68 | 2005 |
| Myalgic encephalomyelitis/chronic fatigue syndrome—metabolic disease or disturbed homeostasis due to focal inflammation in the hypothalamus? E Hatziagelaki, M Adamaki, I Tsilioni, G Dimitriadis, TC Theoharides Journal of Pharmacology and Experimental Therapeutics 367 (1), 155-167, 2018 | 66 | 2018 |
| Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity TC Theoharides, N Sismanopoulos, DA Delivanis, B Zhang, ... Trends in pharmacological sciences 32 (9), 534-542, 2011 | 62 | 2011 |
| Islet transplantation: present clinical situation and future aspects RG Bretzel, M Brendel, M Eckhard, D Brandhorst, C Jaeger, ... Experimental and Clinical Endocrinology & Diabetes 109 (Suppl 2), S384-S399, 2001 | 57 | 2001 |
| Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index E Alexiou, E Hatziagelaki, V Pergialiotis, C Chrelias, D Kassanos, ... Hormone molecular biology and clinical investigation 29 (3), 105-111, 2017 | 56 | 2017 |
| Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus M Guthoff, R Wagner, E Randrianarisoa, E Hatziagelaki, A Peter, ... Scientific reports 7 (1), 40627, 2017 | 55 | 2017 |
| Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans R Wagner, M Heni, K Linder, C Ketterer, A Peter, A Böhm, E Hatziagelaki, ... Acta diabetologica 51, 71-78, 2014 | 53 | 2014 |
| Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry KA Hunt, DJ Smyth, T Balschun, M Ban, V Mistry, T Ahmad, V Anand, ... Nature genetics 44 (1), 3-5, 2012 | 52 | 2012 |
John LekakisNational and Kapodistrian University of Athens, Medical School在 med.uoa.gr 的电子邮件经过验证
